Sakandal, Jibreil S.

HRN: 27-35-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 750MG (VIAL)
06/23/2025
06/29/2025
IV
440mg
Q8h
URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: